Jonathan Biller - Chief Financial Officer at Agios Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Financial Officer
Stock Symbol
AGIO on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Jonathan Biller since 9/18/2023

Holdings reported by Jonathan Biller for Agios Pharmaceuticals, Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common stock 23K $497K $21.64 Feb 22, 2022 Direct
Restricted stock units 11.5K $285K $24.79 Mar 1, 2022 Direct Common stock
Performance share units 8.52K $184K $21.64 Feb 18, 2022 Direct Common stock
Stock options (right to buy) 41K Mar 1, 2022 Direct Common stock

Transactions reported by Jonathan Biller for Agios Pharmaceuticals, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.